Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker

Proteome Science

Volumn 7, Issue , 2009, Pages

  Aguilar Mahecha, Adriana ^a   Cantin, Christiane ^b   O'Connor McCourt, Maureen ^b   Nantel, Andre ^b   Basik, Mark ^a  

^a MCGILL UNIVERSITY   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTERMETHOD COMPARISON; NORMAL HUMAN; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN MICROARRAY; RELIABILITY; REPRODUCIBILITY; VALIDATION STUDY;

EID: 65449120329     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-7-15     Document Type: Article

References (46)

1. Cretich M Damin F Pirri G Chiari M Protein and peptide arrays: Recent trends and new directions Biomol Eng 2006, 23:77-88 16527536
2. Liotta LA Espina V Mehta AI Calvert V Rosenblatt K Geho D Munson PJ Young L Wulfkuhle J Petricoin EF 3rd Protein microarrays: Meeting analytical challenges for clinical applications Cancer Cell 2003, 3:317-325 12726858
3. VanMeter A Signore M Pierobon M Espina V Liotta LA Petricoin EF 3rd Reverse-phase protein microarrays: Application to biomarker discovery and translational medicine Expert Rev Mol Diagn 2007, 7:625-633 17892368
4. Charboneau L Tory H Chen T Winters M Petricoin EF 3rd Liotta LA Paweletz CP Utility of reverse phase protein arrays: Applications to signalling pathways and human body arrays Brief Funct Genomic Proteomic 2002, 1:305-315 15239896
5. Paweletz CP Charboneau L Bichsel VE Simone NL Chen T Gillespie JW Emmert-Buck MR Roth MJ Petricoin IE Liotta LA Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front Oncogene 2001, 20:1981-1989 11360182
6. Mendes KN Nicorici D Cogdell D Tabus I Yli-Harja O Guerra R Hamilton SR Zhang W Analysis of signaling pathways in 90 cancer cell lines by protein lysate array J Proteome Res 2007, 6:2753-2767 17564428
7. Spurrier B Ramalingam S Nishizuka S Reverse-phase protein lysate microarrays for cell signaling analysis Nat Protoc 2008, 3:1796-1808 18974738
8. Ramaswamy A Lin E Chen I Mitra R Morrisett J Coombes K Ju Z Kapoor M Application of protein lysate microarrays to molecular marker verification and quantification Proteome Sci 2005, 3:9 1334216 16281978
9. Janzi M Odling J Pan-Hammarstrom Q Sundberg M Lundeberg J Uhlen M Hammarstrom L Nilsson P Serum microarrays for large scale screening of protein levels Mol Cell Proteomics 2005, 4:1942-1947 16131484
10. Kujiraoka T Hattori H Miwa Y Ishihara M Ueno T Ishii J Tsuji M Iwasaki T Sasaguri Y Fujioka T et al Serum apolipoprotein j in health, coronary heart disease and type 2 diabetes mellitus J Atheroscler Thromb 2006, 13:314-322 17192696
11. Leskov KS Klokov DY Li J Kinsella TJ Boothman DA Synthesis and functional analyses of nuclear clusterin, a cell death protein J Biol Chem 2003, 278:11590-11600 12551933
12. Zellweger T Kiyama S Chi K Miyake H Adomat H Skov K Gleave ME Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumour model BJU Int 2003, 92:463-469 12930442
13. Shannan B Seifert M Leskov K Willis J Boothman D Tilgen W Reichrath J Challenge and promise: Roles for clusterin in pathogenesis, progression and therapy of cancer Cell Death Differ 2006, 13:12-19 16179938
14. Pucci S Bonanno E Pichiorri F Angeloni C Spagnoli LG Modulation of different clusterin isoforms in human colon tumorigenesis Oncogene 2004, 23:2298-2304 14755245
15. Lourda M Trougakos IP Gonos ES Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of Clusterin/Apolipoprotein J Int J Cancer 2007, 120:611-622 17096323
16. Kricka LJ Master SR Validation and Quality Control of Protein Microarray-Based Analytical Methods 2005, 114:233-255 16156108
17. Bodovitz S Joos T The proteomics bottleneck: Strategies for preliminary validation of potential biomarkers and drug targets Trends Biotechnol 2004, 22:4-7 14690616
18. Nishizuka S Charboneau L Young L Major S Reinhold WC Waltham M Kouros-Mehr H Bussey KJ Lee JK Espina V et al Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays Proc Natl Acad Sci USA 2003, 100:14229-14234 283574 14623978
19. Zong Y Zhang S Chen HT Zong Y Shi Y Forward-phase and reverse-phase protein microarray Methods Mol Biol 2007, 381:363-374 17984529
20. Espina V Wulfkuhle J Calvert VS Liotta LA Petricoin EF 3rd Reverse phase protein microarrays for theranostics and patient-tailored therapy Methods Mol Biol 2008, 441:113-128 18370315
21. Srivastava M Eidelman O Jozwik C Paweletz C Huang W Zeitlin PL Pollard HB Serum proteomic signature for cystic fibrosis using an antibody microarray platform Mol Genet Metab 2006, 87:303-310 16406648
22. Grote T Siwak DR Fritsche HA Joy C Mills GB Simeone D Whitcomb DC Logsdon CD Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: Accurate detection of CA19-9 levels in pancreatic cancer Proteomics 2008, 8:3051-3060 18615426
23. Muller U Papen R Manufacturing of 2-D Arrays by Pin-printing Technologies Microarray Technology and Its Applications Springer Berlin Heidelberg Müller U, Nicolau DV 2005:73-88
24. Fan YH Hu Z Li C Wang LE Guo Z Qiao Y Zhang L Zhang W Mao L Wei Q In vitro expression levels of cell-cycle checkpoint proteins are associated with cellular DNA repair capacity in peripheral blood lymphocytes: A multivariate analysis J Proteome Res 2007, 6:1560-1567 2579792 17362036
25. Park MY Choi SC Lee HS Kim D Baek KE Kim JT Lim JS Yeom YI Chung JW Kim JW et al A quantitative analysis of N-myc downstream regulated gene 2 (NDRG 2) in human tissues and cell lysates by reverse-phase protein microarray Clin Chim Acta 2008, 387:84-89 17936257
26. Majidi M Al-Wadei HA Takahashi T Schuller HM Nongenomic beta estrogen receptors enhance beta1 adrenergic signaling induced by the nicotine-derived carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human small airway epithelial cells Cancer Res 2007, 67:6863-6871 17638897
27. Stevens EV Nishizuka S Antony S Reimers M Varma S Young L Munson PJ Weinstein JN Kohn EC Pommier Y Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers Mol Cancer Ther 2008, 7:10-18 18187810
28. Nijdam AJ Ming-Cheng Cheng M Geho DH Fedele R Herrmann P Killian K Espina V Petricoin EF 3rd Liotta LA Ferrari M Physicochemically modified silicon as a substrate for protein microarrays Biomaterials 2007, 28:550-558 16987550
29. Angenendt P Glokler J Murphy D Lehrach H Cahill DJ Toward optimized antibody microarrays: A comparison of current microarray support materials Anal Biochem 2002, 309:253-260 12413459
30. Ingvarsson J Larsson A Sjoholm AG Truedsson L Jansson B Borrebaeck CA Wingren C Design of recombinant antibody microarrays for serum protein profiling: Targeting of complement proteins J Proteome Res 2007, 6:3527-3536 17696517
31. Wingren C Ingvarsson J Dexlin L Szul D Borrebaeck CA Design of recombinant antibody microarrays for complex proteome analysis: Choice of sample labeling-tag and solid support Proteomics 2007, 7:3055-3065 17787036
32. Olle EW Messamore J Deogracias MP McClintock SD Anderson TD Johnson KJ Comparison of antibody array substrates and the use of glycerol to normalize spot morphology Exp Mol Pathol 2005, 79:206-209 16246325
33. Schäferling M Kambhampati D Protein Microarray Surface Chemistry and Coupling Schemes Protein Microarray Technology Wiley-VCH Kambhampati D 2004:11-38
34. Feng JT Liu YK Song HY Dai Z Qin LX Almofti MR Fang CY Lu HJ Yang PY Tang ZY Heat-shock protein 27: A potential biomarker for hepatocellular carcinoma identified by serum proteome analysis Proteomics 2005, 5:4581-4588 16240287
35. Newkirk MM Apostolakos P Neville C Fortin PR Systemic lupus erythematosus, a disease associated with low levels of clusterin/apoJ, an antiinflammatory protein J Rheumatol 1999, 26:597-603 10090169
36. Trougakos IP Poulakou M Stathatos M Chalikia A Melidonis A Gonos ES Serum levels of the senescence biomarker clusterin/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction Exp Gerontol 2002, 37:1175-1187 12470829
37. Chen X Halberg RB Ehrhardt WM Torrealba J Dove WF Clusterin as a biomarker in murine and human intestinal neoplasia Proc Natl Acad Sci USA 2003, 100:9530-9535 170952 12886021
38. Nakamura E Abreu-e-Lima P Awakura Y Inoue T Kamoto T Ogawa O Kotani H Manabe T Zhang GJ Kondo K et al Clusterin is a secreted marker for a hypoxia-inducible factor-independent function of the von Hippel-Lindau tumor suppressor protein Am J Pathol 2006, 168:574-584 1606480 16436671
39. Chi KN Siu LL Hirte H Hotte SJ Knox J Kollmansberger C Gleave M Guns E Powers J Walsh W et al A phase I study of OGX-011, a 2′-methoxyethyl phosphorothioate antisense to clusterin, in combination with docetaxel in patients with advanced cancer Clin Cancer Res 2008, 14:833-839 18245546
40. Schmitz G Drug evaluation: OGX-011, a clusterin-inhibiting antisense oligonucleotide Curr Opin Mol Ther 2006, 8:547-554 17243491
41. Ahnadi CE Sabrinah Chapman E Lepine M Okrongly D Pujol-Moix N Hernandez A Boughrassa F Grant AM Assessment of platelet activation in several different anticoagulants by the Advia 120 Hematology System, fluorescence flow cytometry, and electron microscopy Thromb Haemost 2003, 90:940-948 14597991
42. Witte DP Aronow BJ Stauderman ML Stuart WD Clay MA Gruppo RA Jenkins SH Harmony JA Platelet activation releases megakaryocyte-synthesized apolipoprotein J, a highly abundant protein in atheromatous lesions Am J Pathol 1993, 143:763-773 1887200 8362975
43. Jenkins SH Stuart WD Bottoms LA Harmony JA Quantitation of plasma apolipoprotein J Methods Enzymol 1996, 263:309-316 8749017
44. Berglund L Bjorling E Oksvold P Fagerberg L Asplund A Szigyarto CA Persson A Ottosson J Wernerus H Nilsson P et al A genecentric Human Protein Atlas for expression profiles based on antibodies Mol Cell Proteomics 2008, 7:2019-2027 18669619
45. Yocum AK Chinnaiyan AM Current affairs in quantitative targeted proteomics: Multiple reaction monitoring-mass spectrometry Brief Funct Genomic Proteomic 2009 19279071
46. Issaq HJ Veenstra TD Would you prefer multiple reaction monitoring or antibodies with your biomarker validation? Expert Rev Proteomics 2008, 5:761-763 19086854